|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-4-22
|
|
pubmed:abstractText |
Non-germinal center (non-GC) phenotype, high level expression of the transcription factor forkhead box protein P1 (FOXP1) and anti-apoptotic protein Bcl-2 have been identified as unfavorable prognostic factors for diffuse large B-cell lymphoma (DLBCL) patients treated with chemotherapy. Our aim was to re-evaluate the prognostic impact of these biologic factors on the survival of the patients treated with immunochemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1600-0609
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
364-72
|
|
pubmed:meshHeading |
pubmed-meshheading:19141121-Adolescent,
pubmed-meshheading:19141121-Adult,
pubmed-meshheading:19141121-Aged,
pubmed-meshheading:19141121-Aged, 80 and over,
pubmed-meshheading:19141121-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19141121-Female,
pubmed-meshheading:19141121-Forkhead Transcription Factors,
pubmed-meshheading:19141121-Germinal Center,
pubmed-meshheading:19141121-Humans,
pubmed-meshheading:19141121-Immunohistochemistry,
pubmed-meshheading:19141121-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:19141121-Male,
pubmed-meshheading:19141121-Middle Aged,
pubmed-meshheading:19141121-Prognosis,
pubmed-meshheading:19141121-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:19141121-Repressor Proteins,
pubmed-meshheading:19141121-Retrospective Studies,
pubmed-meshheading:19141121-Risk Factors,
pubmed-meshheading:19141121-Survival Analysis,
pubmed-meshheading:19141121-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
|
|
pubmed:affiliation |
Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
